Investors

Press Releases

Endonovo Therapeutics Receives Notice of Termination of Its Binding-Letter Agreement to Acquire Rio Grande Neurosciences
Endonovo Therapeutics Files Patent for Treating Chemical and Radiation Injuries Using Next-Generation Biologics
Endonovo Therapeutics Announces Issuance of U.S. Patent on Production of Human Biomolecules
Endonovo Therapeutics Announces New Round of Financing
Endonovo Therapeutics Announces Binding Letter of Intent to Acquire Rio Grande Neurosciences, Inc.
Endonovo Therapeutics Files Continuation Patent for Producing Adult Stem Cell Secretome
Endonovo Therapeutics Awarded Preliminary Injunction Against Kodiak Capital et al
Endonovo Therapeutics Provides Update on Variable Convertible Notes
Endonovo Therapeutics to Present at the 2016 Marcum Microcap Conference in New York
Endonovo Therapeutics to Present at the SeeThruEquity 5th Annual Microcap Investor Conference in New York
RSS
Show All